MET and gastric cancer: Here, we conducted targeted next generation sequencing (NGS) on the circulating tumor DNA (ctDNA) of a stage IV gastric cancer patient, and identified a reservoir of mutations that echoed the mutations found in a contemporaneous tissue biopsy including MET amplification.